Active Ingredient (In Each Softgel)
Docusate Calcium 240 mg
The following Structured Product Label (SPL) was submitted to the FDA by Central Texas Community Health Centers for the product Docusate Calcium (NDC 76413-307). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each softgel), purpose, uses, do not use, ask a doctor before use if, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Docusate Calcium 240 mg
Stool softener
for relief of occasional constipation. This product generally produces a bowel movement within 12 to 72 hours.
you notice a sudden change in bowel habits that persists over a period of 2 weeks.
These could be signs of s serious condition.
ask a health care professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
corn oil, D&C red #33, edible white ink, FD&C red #40, gelatin, glycerin, purified water and sorbitol special.
1-800-645-2158
Compare to active ingredient in SURFAK®*
Safe, Effective, Non-Habit Forming
Stool Softener Laxative DC
Docusate Calcium USP, 240 mg
SOFTGEL CAPSULES
TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
*Rugby Laboratories is not affiliated with the owner of the trademark Surfak®.
Distributed by: Rugby Laboratories
31778 Enterprise Drive
Livonia, MI 48150
www.rugbylaboratories.com
CommUnityCare Federally Qualified Health Centers
DOCUSATE
CALCIUM
240 MG
CAPS
Date:
Name:
Dr.
TAKE 1 CAPSULE BY MOUTH DAILY AS DIRECTED.
123456
1/1/01
DOCUSATE CA.240MG CAPS#30NDC 76413-307-30
Batch: 123456
Lot: 123456
Exp: 1/1/01
MAJOR
Federal law prohibits the transfer of this drug to any other person than the patient for whom prescribed.
* Please review the disclaimer below.